Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Eastern Finland | OTHER |
Not provided
Not provided
Not provided
Not provided
Tramadol-paracetamol combination is studied in patients coming for elective spine surgery. The study drug is started at the day of surgery and continued maximum of five days. Before the surgery pain, use of pain medication, satisfaction for pain medication, adverse effects, resilience, depression and life satisfaction were asked. At the discharge and seven days after the surgery use of pain medication and adverse effects were asked. The patients were followed up to 28 days and one year after surgery.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| tramadol/acetaminophen | Active Comparator | Tramadol-paracetamol two tablets 37,5mg/325mg twice daily up to five days for patients undergoing spinal surgery |
|
| placebo | Placebo Comparator | Placebo two tablets twice daily up to five days for patients undergoing spinal surgery |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| spine surgery | Procedure | Tramadol-paracetamol 325mg/37,5mg two tablets twice daily |
|
| Measure | Description | Time Frame |
|---|---|---|
| Satisfaction for pain medication | satisfaction measured with numeral rating scale 0-10 (0=not satisfied, 10= totally satisfied | one week after surgery |
| Measure | Description | Time Frame |
|---|---|---|
| need for rescue pain medication | Measured as amount of other pain medicines used as rescue medicine | one week after surgery |
| Pain assessment | Pain measered in numeral rating scale 0-10 (0= no pain, 10=worst pain) |
| Measure | Description | Time Frame |
|---|---|---|
| Pain assessment | Pain measered in numeral rating scale 0-10 (0= no pain, 10=worst pain) | one year after surgery |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Merja Kokki, PhD | Kuopio University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Kuopio University Hospital | Kuopio | Northern Savonia | 70029 | Finland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D010146 | Pain |
Not provided
Not provided
Randomised, double blinded, placebo controlled study
Not provided
Not provided
placebo tablets are used
| one week after surgery |
| adverse effects | Patient reported adverse reactions | one week after surgery |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |